Intricate relationship between cancer stemness, metastasis, and drug resistance
MedComm · 2024-10 · 5 (10)
DOI: 10.1002/mco2.710 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 21.09.2024. Verfasst von Tikam Chand Dakal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Genome and Computational Biology Lab Department of Biotechnology Mohanlal Sukhadia University Udaipur Rajasthan India. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 342 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer stem cells (CSCs) are widely acknowledged as the drivers of tumor initiation, epithelial‐mesenchymal transition (EMT) progression, and metastasis. Originating from both hematologic and solid malignancies, CSCs exhibit quiescence, pluripotency, and self‐renewal akin to normal stem cells, thus orchestrating tumor heterogeneity and growth. Through a dynamic interplay with the tumor microenvironment (TME) and intricate signaling cascades, CSCs undergo transitions from differentiated cancer cells, culminating in therapy resistance and disease recurrence. This review undertakes an in‐depth analysis of the multifaceted mechanisms underlying cancer stemness and CSC‐mediated resistance to therapy. Intrinsic factors encompassing the TME, hypoxic conditions, and oxidative stress, alongside extrinsic processes such as drug efflux mechanisms, collectively contribute to therapeutic resistance. An exploration into key signaling pathways, including JAK/STAT, WNT, NOTCH, and HEDGEHOG, sheds light on their pivotal roles in sustaining CSCs phenotypes. Insights gleaned from preclinical and clinical studies hold promise in refining drug discovery efforts and optimizing therapeutic interventions, especially chimeric antigen receptor (CAR)‐T cell therapy, cytokine‐induced killer (CIK) cell therapy, natural killer (NK) cell‐mediated CSC‐targeting and others. Ultimately use of cell sorting and single cell sequencing approaches for elucidating the fundamental characteristics and resistance mechanisms inherent in CSCs will enhance our comprehension of CSC and intratumor heterogeneity, which ultimately would inform about tailored and personalized interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genome and Computational Biology Lab Department of Biotechnology Mohanlal Sukhadia University Udaipur Rajasthan India.
- Department of Zoology M.S. College Motihari Bihar India.
- Department of General Surgery The First Affiliated Hospital of Dalian Medical University Dalian China.
- Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute City of Hope Monrovia California USA.
- Stress Physiology and Molecular Biology Laboratory Department of Botany Jai Narain Vyas University Jodhpur Rajasthan India.
- SAS Polyclinic Mohali Punjab India.
ORCID-Profile: Amit Sharma
Zitieren
APA
Dakal, T. C., Bhushan, R., Xu, C., Gadi, B. R., Cameotra, S. S., Yadav, V., Maciaczyk, J., Schmidt-Wolf, I. G. H., Kumar, A., & Sharma, A. (2024). Intricate relationship between cancer stemness, metastasis, and drug resistance. MedComm, 5(10). https://doi.org/10.1002/mco2.710
Vancouver
Dakal TC, Bhushan R, Xu C, Gadi BR, Cameotra SS, Yadav V, et al. Intricate relationship between cancer stemness, metastasis, and drug resistance. MedComm. 2024;5(10). doi:10.1002/mco2.710
BibTeX
@article{Dakal2024,
author = {Dakal, Tikam Chand and Bhushan, Ravi and Xu, Caiming and Gadi, Bhana Ram and Cameotra, Swaranjit Singh and Yadav, Vikas and Maciaczyk, Jarek and Schmidt-Wolf, Ingo G H and Kumar, Abhishek and Sharma, Amit},
title = {Intricate relationship between cancer stemness, metastasis, and drug resistance},
journal = {MedComm},
year = {2024},
volume = {5},
number = {10},
doi = {10.1002/mco2.710}
}
EUVIMED